Drug Reference
influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen
Brand names
Afluria 2024-2025Afluria 2025-2026Afluria Quadrivalent 2022-2023Afluria Quadrivalent 2023-2024FluMist 2024-2025FluMist 2025-2026FluMist Quadrivalent 2022-2023FluMist Quadrivalent 2023-2024Fluad 2024-2025Fluad 2025-2026Fluad Quadrivalent 2022-2023Fluad Quadrivalent 2023-2024Fluarix 2024-2025Fluarix 2025-2026Fluarix Quadrivalent 2022-2023Fluarix Quadrivalent 2023-2024Flublok 2024-2025Flublok 2025-2026Flublok Quadrivalent 2022-2023Flublok Quadrivalent 2023-2024Flucelvax 2024-2025Flucelvax 2025-2026Flucelvax Quadrivalent 2022-2023Flucelvax Quadrivalent 2023-2024Flulaval 2024-2025Flulaval 2025-2026Flulaval Quadrivalent 2022-2023Flulaval Quadrivalent 2023-2024Fluzone 2024-2025Fluzone 2025 Southern HemisphereFluzone 2025-2026Fluzone 2026 Southern HemisphereFluzone Quadrivalent 2022-2023Fluzone Quadrivalent 2023-2024Fluzone Quadrivalent 2024 Southern HemisphereFluzone Quadrivalent 2025-2026
Available as
0.5 ML · Prefilled Syringe0.03 MG/ML0.7 ML · Prefilled Syringe0.5 ML · Injection158000000 UNT/ML · Nasal Spray
Multi-ingredient product
Influenza A Virus (H1n1) AntigenInfluenza A Virus (H3n2) AntigenInfluenza B Virus Antigen
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- FLUAD (INFLUENZA A VIRUS A/MISSOURI/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)) INJECTION, SUSPENSION [SEQIRUS, INC.]
- FLUCELVAX (INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)) INJECTION, SUSPENSION [BAMBOO US BIDCO LLC]
- FLUZONE HD TIV SH 2026 (INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), AND INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)) INJECTION, SUSPENSION [SANOFI VACCINES US INC.]
- FLUZONE TIV SH 2026 (INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), AND INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)) INJECTION, SUSPENSION [SANOFI VACCINES US INC.]
- FLUMIST (INFLUENZA VACCINE LIVE INTRANASAL) SPRAY [MEDIMMUNE, LLC]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.